Comparison of adverse events during 5‐fluorouracil versus 5‐fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer

BACKGROUND: In clinical trials, combined 5‐fluorouracil (5FU) plus oxaliplatin improves the survival of patients who have resected, stage III colon cancer with manageable toxicity. However, the tolerability of this in the general population of patients with colon cancer is uncertain. METHODS: Advers...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer 2012-09, Vol.118 (17), p.4309-4320
Hauptverfasser:	Sanoff, Hanna K., Carpenter, William R., Freburger, Janet, Li, Ling, Chen, Kun, Zullig, Leah L., Goldberg, Richard M., Schymura, Maria J., Schrag, Deborah
Format:	Artikel
Sprache:	eng
Schlagworte:	adjuvant chemotherapy colon cancer elderly oxaliplatin toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!